Supplemental Grant Application Instructions II-2 . Scenario C. Exempt Human Subjects Research If all of the proposed human subjects research meets the criteria for one or more of the exemptions from the requirements in the HHS regulations (46.101(b)) (see Part III Section 3 under Human Subjects Research
Adults with one of the above listed conditions who have not received any pneumococcal vaccine should get a dose of PCV13 first and should also continue to receive the recommended doses of PPSV23. Ask your health care provider for details.
The Advisory Committee on Immunization Practices (ACIP) recommends that pneumococcal vaccine-nave people age 65 years and older should receive PCV13 first, followed by PPSV23 one year later. If the provider is unwilling to stock PCV13, then patients should be referred elsewhere to get PCV13 first.